The need for improved uptake of the KDIGO glomerulonephritis guidelines into clinical practice in Canada: A survey of nephrologists

Clinical Kidney Journal

Volumn 7, Issue 6, 2014, Pages

  Barbour, Sean ^a,b,c   Beaulieu, Monica ^a,b,c   Gill, Jagbir ^a,b,c   Espino Hernandez, Gabriela ^b   Reich, Heather N ^d   Levin, Adeera ^a,b,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BC Provincial Renal Agency   (Canada)

^c ST PAUL S HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

care gap; glomerulonephritis; guideline implementation; KDIGO; knowledge translation

Indexed keywords

ANGIOTENSIN ANTAGONIST; CALCINEURIN INHIBITOR; CALCIUM; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PREDNISONE; RITUXIMAB; VITAMIN D;

ADULT; ANCA ASSOCIATED VASCULITIS; BEST PRACTICE MANAGEMENT; CANADA; CLINICAL PRACTICE; CONSERVATIVE TREATMENT; CROSS-SECTIONAL STUDY; DECISION SUPPORT SYSTEM; DEMOGRAPHY; FOCAL GLOMERULOSCLEROSIS; GLOMERULONEPHRITIS; HEALTH CARE ACCESS; HEALTH CARE SURVEY; HEALTH INSURANCE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; MEDICAL SPECIALIST; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROLOGIST; NURSING; OSTEOPOROSIS; PATIENT CARE; PATIENT EDUCATION; PLASMAPHERESIS; PNEUMOCYSTIS PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEINURIA; REVIEW; RURAL AREA; SELF REPORT; URBAN AREA; WEB BROWSER;

EID: 84928479883     PISSN: 20488505     EISSN: 20488513     Source Type: Journal    
DOI: 10.1093/ckj/sfu104     Document Type: Review

References (23)

1. Samuel S, Morgan C, Bitzan M et al. Substantial practice variation exists in the management of childhood nephrotic syndrome. Pediatr Nephrol 2013; 28: 2289-2298
2. Manno C, Torres DD, Rossini M et al. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with longterm follow-up in proteinuric IgA nephropathy. Nephrol Dial Transplant 2009; 24: 3694-3701
3. Pozzi C, Andrulli S, Del Vecchio L et al. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J Am Soc Nephrol 2004; 15: 157-163
4. Barbour SJ, Cattran DC, Kim SJ et al. Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease. Kidney Int 2013; 84: 1017-1024
5. Hladunewich MA, Troyanov S, Calafati J et al. The natural history of the non-nephrotic membranous nephropathy patient. Clin J Am Soc Nephrol 2009; 4: 1417-1422
6. Cattran DC, Reich HN, Kim SJ et al. Have we changed the outcome in membranous nephropathy? A propensity study on the role of immunosuppressive therapy. Clin J Am Soc Nephrol 2011; 6: 1591-1598
7. Troyanov S, Wall CA, Miller JA et al. Focal and segmental glomerulosclerosis: definition and relevance of a partial remission. J AmSoc Nephrol 2005; 16: 1061-1068
8. Sprangers B, Bomback AS, Cohen SD et al. Idiopathic membranous nephropathy: clinical and histologic prognostic features and treatment patterns over time at a tertiary referral center. Am J Nephrol 2012; 36: 78-89
9. Cattran DC, Greenwood C, Ritchie S et al. A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group. Kidney Int 1995; 47: 1130-1135
10. Cattran DC, Appel GB, Hebert LA et al. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int 2001; 59: 1484-1490
11. Jha V, Ganguli A, Saha TK et al. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy. J Am Soc Nephrol 2007; 18: 1899-1904
12. Cattran DC, Appel GB, Hebert LA et al. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int 1999; 56: 2220-2226
13. KDIGO clinical practice guidelines for glomerulonephritis. Kidney Int 2012; S2: 139-274
14. Straus SE, Tetroe JM, Graham ID. Knowledge translation is the use of knowledge in health care decision making. J Clin Epidemiol 2011; 64: 6-10
15. Straus SE, Tetroe J, Graham I. Defining knowledge translation. CMAJ 2009; 181: 165-168
16. McGlynn EA, Asch SM, Adams J et al. The quality of health care delivered to adults in the United States. N Engl J Med 2003; 348: 2635-2645
17. Lugtenberg M, Zegers-van Schaick JM, Westert GP et al. Why don't physicians adhere to guideline recommendations in practice? An analysis of barriers among Dutch general practitioners. Implement Sci 2009; 4: 54
18. Majumdar SR, McAlister FA, Furberg CD. From knowledge to practice in chronic cardiovascular disease: a long and winding road. J Am Coll Cardiol 2004; 43: 1738-1742
19. Gonzales R, Steiner JF, Lum A et al. Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA 1999; 281: 1512-1519
20. Kiefe CI, Allison JJ,Williams OD et al. Improving quality improvement using achievable benchmarks for physician feedback: a randomized controlled trial. JAMA 2001; 285: 2871-2879
21. Leaf DE, Appel GB, Radhakrishnan J. Glomerular disease: why is there a dearth of high quality clinical trials? Kidney Int 2010; 78: 337-342
22. Pesce F, Schena FP. Worldwide distribution of glomerular diseases: the role of renal biopsy registries. Nephrol Dial Transplant 2010; 25: 334-336
23. Adams AS, Soumerai SB, Lomas J et al. Evidence of self-report bias in assessing adherence to guidelines. Int J Qual Health Care 1999; 11: 187-192